Clinical Trial

Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.

Study acronym: ARTROCELL
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated May 2025 completion). Its status may not reflect the trial's current state.
Summary
Phase III, multicenter, randomized, open-label, multicenter clinical trial comparing treatment with allogeneic mesenchymal cells versus autologous mesenchymal cells and versus active control with hyaluronic acid in patients with knee osteoarthritis.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-10-08; most recent amendment 2024-11-26.
Status change: Recruiting → Active, Not Recruiting 2024-05-08
Status change: Active, Not Recruiting → Recruiting 2022-05-27
Trial Details
NCT Number NCT05086939
Lead Sponsor Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Collaborators: Instituto de Investigación Biomédica de Salamanca, Spanish Clinical Research Network - SCReN, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Universitari de Bellvitge
Conditions Knee Osteoarthritis
Enrollment 124 participants
Start Date 2021-05-26
Primary Completion 2025-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2024-11-29